The Prescribing Data Restriction Program: Critical Assessment and Best Practices Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. ...more

Market Study September 2006

Opportunities in Stem Cell Research and Commercialization:Technology advances, regulatory impact and key players This new report analyzes the key factors impacting the commercial exploitation of adult, fetal and ...more

Market Study May 2006

Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition This report assesses the current and future position of biologics in the fields of multiple sclerosis, ...more

Market Study May 2006

Pharmaceutical and Biotech Market Entrance Strategies: Pricing,Reimbursement and Paralle Trade Pharmaceutical and Biotech Market Entrance Strategies examines the key issues that need to be addressed ...more

Market Study March 2006

Cancer Therapeutics 2006: Market Dynamics and R&D Trends Examines four major cancer markets in light of newly emerging therapeutics, shifting market shares and ...more

Management Report December 2005

US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts One major finding that emerges from this analysis is the surprising absence of the majority of US ...more

Management Report September 2005

Pain Therapeutics 2005 (market briefing) Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and information concerning ...more

Management Report May 2005

Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing (market briefing) Provides members of pharmaceutical, biotechnology and clinical research sectors an analytically-based ...more

Management Report March 2005